ロード中...
An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network
AIM: Fenofibrate, a PPAR-α inhibitor used for treating dyslipidemia, has well-documented anti-inflammatory effects that vary between individuals. While DNA sequence variation explains some of the observed variability in response, epigenetic patterns present another promising avenue of inquiry due to...
保存先:
| 出版年: | Pharmacogenomics |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Future Medicine Ltd
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5593083/ https://ncbi.nlm.nih.gov/pubmed/28835163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2017-0037 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|